Viridian Therapeutics Inc banner

Intrinsic Value

The intrinsic value of Viridian Therapeutics Inc (0K1R) under the Base Case is USD per share. Compared with the current market price of 30.06 USD, the stock appears .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

0K1R Intrinsic Value

What one share is worth in the bear, base and bull cases.

Create a free account · No card needed

Do our valuations actually work? See backtest results .

Alert me when 0K1R is below its intrinsic value
Today Hidden ·
0K1R Valuation History

Intrinsic value next to the price over the past 5 years.

Create a free account · No card needed

Alternatives to 0K1R

Fundamental Analysis

What Viridian Therapeutics Does

Biotechnology Health Care

Viridian Therapeutics is a biotechnology company that develops antibody medicines for serious autoimmune and rare diseases. Its main scientific focus is thyroid eye disease, a condition where the immune system attacks tissue around the eyes and can cause pain, swelling, and vision problems. The company is built around drug discovery and clinical development rather than drug manufacturing or retail sales.

Headquarters
United States of America US
Employees
252
IPO date
Jun 18, 2014
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Latest Earnings Call

Q3 2026 · November 4, 2026

Viridian said Lumvoa’s first launch quarter exceeded expectations, while advancing pipeline milestones in thyroid eye disease and other autoimmune diseases.

Open the earnings call
EPS
−$0.81
Expected
−$1.01
Surprise
+19.8%
Stock, day of the call
+15.5%
View Earnings Call

Viridian Therapeutics insiders are buying within their usual range

Insider trading · Last trade on Aug 19, 2026

Sold $174k 1 insider
Bought $20m 1 insider
Trades by date
Open insider trading

Past 12 months

Continue 0K1R Research

Decided on Viridian Therapeutics? Get an email when 0K1R reaches the price you’d buy at. Free with an account.

Other Viridian Therapeutics listings

What is the Intrinsic Value of one 0K1R stock?

The intrinsic value for Viridian Therapeutics Inc (0K1R) under the Base Case is USD.

Is 0K1R stock undervalued or overvalued?

Compared with the current market price of 30.06 USD, the stock appears .

How reliable are our estimates? See how past valuations played out
Back to Top